Comparison and Contrast of Bone and Dentin in Genetic Disorder, Morphology and Regeneration: A Review

Article information

J Bone Metab. 2021;28(1):1-10
Publication date (electronic) : 2021 February 28
doi :
1College of Dental Medicine, Columbia University, New York, USA
2Laboratory for the Study of Regenerative Dental Medicine, Department of Oral Histology-Developmental Biology & Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea
Corresponding author: Joo-Cheol Park, Laboratory for the Study of Regenerative Dental Medicine, Department of Oral Histology-Developmental Biology & Dental Research Institute, School of Dentistry, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea, Tel: +82-2-880-2335, Fax: +82-2-878-2338, E-mail:

Jaehyun Kim, Gayeong Lee, and Woo Sung Chang contributed equally to this work and should be considered co-first authors.

Received 2020 October 31; Revised 2020 December 8; Accepted 2020 December 18.


The bone and dentin have distinct healing processes. The healing process of bones is regenerative, as newly formed tissues are morphologically and functionally similar to the original bone structures. In contrast, the healing process of dentin is reparative due to its failure to replicate some of its key morphological features. In this review, we compare and contrast the healing processes of bone and dentin. We describe how distinct morphological and physiological structures of the 2 tissues translate into different signaling molecules, growth factors, and matrix protein secretion.


As mineralized tissues, bone and dentin have some similar characteristics. The cells of both tissues secrete extracellular matrix (ECM). Odontoblasts and osteoblasts deposit a non-mineralized, type I collagen-rich matrix—called predentin and osteoid, respectively.[1] In bone, inorganic ECM, comprising 65% of the matrix, mainly consists of hydroxyapatite that forms as a result of interactions between minerals and the matrix. Dentin ECM is more mineralized than bone at 72%. The organic ECM, comprising 35% of the matrix, contains collagenous proteins (90%) and non-collagenous proteins (10%).[2] The collagenous portion is mainly constituted of type I collagen, with trace amounts of type III and V collagen. The non-collagenous proteins can be classified into γ-carboxyglutamate-containing proteins, proteoglycans, glycoproteins, and small integrin-binding ligands N-linked glycoproteins (SIBLINGs). The SIBLING family of proteins includes bone sialoprotein (BSP), dentin matrix acidic phosphoprotein 1 (DMP1), dentin sialophosphoprotein (DSPP), osteopontin (OPN), and matrix extracellular phosphoglycoprotein (MEPE). SIBLING proteins are believed to play key biological roles; share an arginine-glycine-aspartic acid (RGD) sequence that facilitates cell attachment, migration, and differentiation; and trigger intracellular transduction by binding to cell surface receptors such as integrin.[1]

BSP is expressed in mineralized tissues, promotes bone formation, and initiates matrix mineralization. It acts as a nucleator of the initial apatite crystal and later as an inhibitor directing the growth of the crystal.[3] BSP is expressed considerably less in dentin than bone, as it constitutes about 1% of the total non-collagenous proteins in dentin. While not much is known about BSP’s role in dentin formation, it is suspected to intensify collagen fibrillation and promote crystal nucleation, with its RGD sequence favoring cell adhesion to the ECM.[4] DSPP is cleaved rapidly into dentin sialoprotein (DSP) in the N-terminus, dentin glycoprotein in the middle, and dentin phosphoprotein (DPP) in the C-terminus. The DPP domain is the DSPP portion that contains the RGD sequence and activates mitogen-activated protein kinase (MAPK) and SMAD by interacting with integrin. The DSP domain acts as a ligand in interaction with integrin B6 and participates in intracellular signaling to promote dental mesenchymal cell differentiation.[5] DSP is believed to be responsible for the initiation of dentin mineralization, while DPP is involved in the maturation of mineralized dentin. Just as a small amount of BSP is found in dentin, DSP is found in rat long bones about 1/400 of dentin.[1] Therefore, despite their names, it would be inappropriate to think of BSP or DSP as bone- or dentin-specific, respectively. DMP1—expressed in bone, dentin, and cementum—regulates phosphate metabolism and promotes bone mineralization.[6] It is believed that the role of DMP1 overlaps with that of DSPP. DSPP is known to participate in the matrix mineralization process of dentinogenesis and osteogenesis. However, in addition to mineralization, DMP1 participates in gene regulation, fibroblast growth factor (FGF) 23 dynamics, and phosphorus metabolism.[6] Additionally, DMP1 was found to go through proteolytic processing, and its fragments play separate roles, as the N-terminus is found in unmineralized predentin, while the C-terminus is found in mineralized dentin.[7] OPN is expressed in osteoblasts, odontoblast, and osteocytes. It regulates bone formation, mineralization, and turnover by inhibiting apatite formation and growth through osteoclast and osteoclastogenesis activity.[1,8] OPN also is believed to anchor osteoclast to the bone surface during bone resorption.[9] MEPE, expressed in osteocytes and dentin, binds strongly to hydroxyapatite minerals in the ECM. MEPE’s involvement in mineralization inhibition and phosphate metabolism regulation was confirmed, with MEPE-null mice showing increased bone mass, while MEPE-overexpressed mice showing decreased bone mass.[10] SIBLING proteins are found not only in mineralized tissues but also in salivary glands and prostate tumors.[11] More research is needed to identify the mechanisms of action and interactions among members of the SIBLING protein family, especially in tissues in which a particular protein does not seem to play a predominant role.

The fact that bone and dentin are both mineralized tissues makes them vulnerable to hereditary mineralization defects, such as hypophosphatemic rickets and osteogenesis imperfecta. However, bone and dentin have morphological differences that make them react differently to injury. In this review article, we describe some of the similarities and differences in bone and dentin, with an emphasis on their healing processes.


Because of the similarities in dentin and bone, some disorders that disrupt mineralization result in abnormalities in both types of tissue. Two such genetic disorders are hypophosphatemic rickets and osteogenesis imperfecta.

X-linked hypophosphatemic rickets—the most commonly inherited pattern among hypophosphatemic rickets—is from a mutation in the phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) gene. PHEX is involved in calcium and phosphate metabolism and is expressed by osteoblasts, osteocytes, and odontoblast. PHEX interacts with MEPE and protects the C-terminal site from cleavage, which is immediately upstream of the acidic serine-and aspartate-rich motif (ASARM).[12] When the PHEX gene is mutated, a peptide in the MEPE’s ASARM region is liberated and inhibits osteoblast bone morphogenetic proteins 2 (BMP2)-mediated mineralization.[13] The consequences of this mineralization inhibition are manifested clinically in both bone and dentin through leg bowing, short stature, high bone mass, and spontaneous infectious tooth abscesses.[14]

Osteogenesis imperfecta is an autosomal dominant disorder caused by a mutation of the COL1A1 or COL1A2 genes that encode type I collagen, and, less commonly, CRTAP or LEPRE1 genes.[14] Type I collagen mutations significantly affect bone flexibility and strength, giving this disorder the nickname, brittle bone disease.[15] Osteogenesis imperfecta’s type I, the most common type of the disease, has milder clinical features such as fragile bones, blue sclera, early deafness, dentinogenesis imperfecta type I, growth deficiency, and joint laxity. Dentinogenesis imperfecta is characterized by yellow or gray tooth discoloration, rapid attrition, bulbous crowns, and early pulp obliteration. Additionally, in dentinogenesis imperfecta type I patients, collagen fibril diameter is reduced and dentin hardness is impaired, highlighting the important role collagen plays in dentin stability.[16]


Bone formation is followed by either intramembranous or endochondral ossification. The bone deposition of the former is completed directly through osteoblasts, which differentiate from mesenchymal progenitors through transcription factor cbfa/runx2; the latter of the bone formation is followed by osteochondroprogenitor. Although the 2 ossification processes stem from different sources, they eventually merge at final bone depositing steps – proliferation, matrix maturation, and mineralization – by preosteoblasts. Some osteoblasts are also differentiated into osteocytes, which are located in narrow interconnecting passage ways within bone matrix – bone canaliculi.[17] Nevertheless, the process by which osteoblasts are fixed into bone matrix and molecular mechanism behind its conversion into osteocytes are yet to be discovered.[18]

Osteoclasts are multinucleated cells that are responsible for bone resorption. They are of hematopoietic origin. Macrophage colony-stimulating factor (M-CSF) and the receptor activator of nuclear factor-κB ligand (RANKL) are responsible for the differentiation and activity of osteoclasts. M-CSF and RANKL bind to their respective receptors, c-Fms and RANK, that are expressed on the cell surface of osteoclast progenitor cells, They stimulate differentiation and regulation of osteoclasts via intracellular signaling pathway system.[19]

1. Structure

Bone is organized in a hierarchical order, from nanometer- to millimeter-sized structures.[20] This well-constructed organization produces the stiffness and toughness that provides mechanical support to the bone. The way in which major components are organized vary and is a differentiating factor between members of the bone family.[21] Bone structure is further complicated by the hierarchical levels of bone organization.

Bone is a compound of 3 major components. Approximately 65% of bone (by weight) is mineral, 25% is organic materials, and 10% is water. Carbonated apatite, the only mineral in bone, is found as extremely small crystals in a highly ordered arrangement.[22,23] Of the 25% of bone that is organic material, 90% is composed of type 1 collagen and the remainder of non-collagenous proteins (NCPs).[20] While the collagen’s basic structure is a triple-helix form, each arrangement may vary, as they tend to join with one another.[20,24] Depending on its location within the bone tissue, this property also can influence mechanical stiffness. Although the organic materials in bone include more than 200 NCPs, there is not sufficient evidence showing they provide mechanical support in the tissue.[25] Lastly, water fills in the gaps between each triple-helix fibril, as well as between fibrils and fibers.[26] The relative proportions of these major components remain nearly the same, except that the mineral components increase overtime at the expense of water.[21]

The layers of crystals positioned within the collagen fibril continue to grow until they fuse together and compress the triple helix model to form lengthy sheets.[27] Once mineralized by crystals, collagen fibrils are grouped in bundles.[28] Although these bundles are positioned along their lengths, their overall structure varies from place to place, because they tend to fuse with other mineralized collagen fibers to form an extended framework.[29] These structures include parallel-, woven fiber-, and plywood-like structures.[21]

Bone is known to undergo internal remodeling of itself, and the cells playing distinct roles that balance each other in this process. Osteoclasts are bone-resorbing cells typically found on the bone surface that demineralize the matrix by creating an acidic environment. Once osteoclasts hollow out a big tunnel, it is refilled with layers of mineralized collagen fibrils and osteoblasts depositing lamellar bone. Lamellae make up the bone’s basic metabolic unit, which is called an osteon. Within an osteon are osteocytes, which are mature osteoblasts entrapped in the matrix they secreted. This property is why the bone cross-section is described as having an onion-like structure, as it contains layers of lamellae surrounding a central blood vessel.[21]

Both compact and trabecular bones consist of layers of lamellae, which are classified into 3 distinct types: concentric, interstitial, and circumferential. Concentric lamellae surround an osteon. Within each osteon is a Haversian canal, where capillaries are located. Haversian canals are connected to each other by Volkmann’s canals, which run horizontally to provide a network throughout the bone. Osteocytes communicate with each other through a network of long, cytoplasmic extensions in canaliculi. Interstitial lamellae are previously concentric lamellae that have been pushed outward as a result of bone remodeling to fill the space between concentric lamellae. Circumferential lamellae from the perimeter of the bone, bordering periosteum on the outer side and bone marrow on the inner side.[30]

2. Repair and regeneration process

Bone shows unique reparative characteristics following damage, mainly fractures. There are 2 types of bone healing: primary and secondary (Fig. 1). Primary bone healing is only possible when 2 fragmented parts are secured together by orthopedic fixative methods. This type of healing does not involve callus formation; rather, bone remodeling by osteoblasts and osteoclasts results in direct bone healing.[31,32]

Fig. 1

Schematic representation of secondary bone healing process in 4 overlapping stages.

The most common type of bone healing is secondary bone healing, which follows a slight movement at the fracture site.[33] Secondary bone healing takes place in four overlapping stages.[3436] Following the injury, blood vessel and musculoskeletal system disruption occurs concurrently. Therefore, the secondary bone healing process is initiated through the activation of a coagulation cascade, which leads to hematoma formation. The hematoma serves as a transient framework that facilitates stem cell differentiation, in which these cells later convert into fibrous tissue, cartilage, and bone.[37] Angiogenesis is stimulated at the same time, forming new blood vessels from preexisting ones. These new blood vessels supply nutrients and various cell types including fibroblasts, stem cells, and inflammatory cells.[35] Next, the inflammatory response produces swelling, heat, and pain, along with the secretion of various growth factors and cytokines, which contribute significant roles in the bone healing process.[35,36,38,39]

Hematoma formation ensues, forming soft (internal) callus and hard (external) callus. Tissue forms at a fractured site, which later is replaced by fibrocartilage that hardens into soft callus with calcium hydroxyapatite.[40] Soft callus can be mineralized further via endochondral ossification into a hard callus of woven bone.[33,40] At the same time, a hard callus can form independently at the periosteum via intramembranous ossification that facilitates direct bone formation.[40]

Lastly, bone remodeling replaces the fractured callus with the secondary bone. In this final stage of the healing process, both soft and hard callus are reduced in size, eventually reaching a size similar to that of the pre-fracture state.[40] The vasculature system returns to the normal state, as well.[40]

One of the distinguishing features of bone is its rich vascular network. Bones receive blood from proximal, distal epiphyseal, metaphyseal, diaphyseal, and periosteal arteries.[41] This vasculature supplies tissues with blood, nutrients, growth factors, hormones, cytokines, and chemokines, allowing for effective communication with neighboring tissues.[42,43] The vascular system is restored via 2 main signaling pathways. First, platelets serve as the first responders at the site, binding to subendothelium’s exposed collagen and initiating the coagulation cascade. Subsequent hematoma formation then releases several signaling molecules and angiogenic growth factors. Moreover, the subsequent hypoxic environment that follows the injury initiates an angiogenic pathway for bone regeneration together with osteoblasts.[42,44,45] Osteoblasts in turn affect endothelial cell proliferation, differentiation, and secretion of osteogenic growth factors by endothelial cells.[42,44,45] Once angiogenesis takes place, new vasculatures recruit and control migration of other inflammatory cells and repair cells as described previously.[4651]

During the bone healing process, the following 3 types of blood vessels are enhanced to increase the blood supply to the fracture site: medullary, periosteal, and osseous arteries.[41,52] The newly generated blood supplies to the callus and cortical bone persist until the medullary blood supply is fully generated, allowing the metabolically active, regenerating callus to be supplied with nutrients and signaling molecules, along with osteoblast/osteoclast precursors.[37,52]

Angiogenesis is mediated by several growth factors and signaling molecules: platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), FGF, BMP, and transforming growth factor-β (TGF-β).[40] It has been reported that VEGF plays a crucial role in the bone-repair cascade by acting as a central mediator for angiogenesis and regulating the activity of these pro-angiogenic factors.[53] VEGF expression is induced by the presence of these growth factors, and cytokines are produced in response to hypoxia in osteoclasts.[37,40] In addition to the recruitment and survival of osteoblasts and osteoclasts, VEGF is involved in the mobilization, recruitment, differentiation, and proliferation of endothelial progenitor cells.[47,49,51, 5456] VEGF is elevated, especially at the site near the fracture, to exert a potent angiogenic activity at the injury site. When VEGF is inhibited, the angiogenic activity of other pro-angiogenic growth factors is prevented, as well.[54,57]

Damage to the blood vessel underneath and subsequent hematoma formation leads to various systemic and local responses. Systemically, parathyroid hormone, growth hormone, steroids, calcitonin, and vitamin D affect bone metabolism and vascularity.[35] Locally, platelets and the hypoxic environment mediate the healing process.[42,44,45] Various types of inflammatory cells near the injured site produce FGF, TGF, BMP, insulin-like growth factor, PDGF, and VEGF.[3436,38,58,59]

TGF-β—released by degranulating platelets—promotes bone repair by recruiting and proliferating mesenchymal cells.[60,61] Once the mesenchymal cells differentiate into chondrocytes, osteoblasts, and osteoclasts, their activities (e.g., differentiation, ECM production, and osteoblast/osteoclast coupling) also respond to TGF-β, with these cells also producing TGF-β.[40] Mesenchymal cells at the periphery of the injury differentiate into osteoblasts that lay down osteoids. Osteoids go through further mineralization steps to eventually restore the bone’s original shape, structure, and mechanical properties.[62] Because of these roles, TGF-β is suspected to modulate the activity of FGF-2, which induces angiogenesis and mitogenesis of mesenchymal cells and osteoblasts.[6365]


For ectomesenchymal cells in the most peripheral layer of dental papilla to differentiate into odontoblasts, it requires cell-ECM-mediated epithelio-mesenchymal interaction. Crown dentin requires interaction with pre ameloblast while root dentin requires interaction with inner enamel epithelium of Hertwig’s epithelial root sheath.[66] In addition, molecular signals from basal lamina such as wnt-10a, TGF-β1, TGF-β2, TGF-β3, FGF-1 are essential for the differentiation of odontoblasts.[6769]

1. Structure

Primary and secondary dentin is composed of tubular structures. With odontoblast cell bodies located at the periphery of the pulp, their cellular processes cross the predentin and run in canaliculi that traverse the dentin layer up to the dentinoenamel junction, resulting in a structure referred to as dentinal tubules. The tubular nature of dentine gives an unusual degree of permeability to this hard tissue, which can promote carious processes and enhance the pulp’s response to dental restorative procedures.[30] The 2 main layers of dentin are the outermost mantle layer and the circumpulpal dentin (the largest part of the dentin layer). Circumpulpal dentin can be categorized into 2 types: intertubular and peritubular dentin. Intertubular dentin refers to the dentin between tubules, consisting of a tightly interwoven network of type I collagen fibrils in and around which apatite crystals are deposited. Fibrils are arranged randomly in a plane at roughly right angles to the dentinal tubules. Its ground substance consists of NCPs and some plasma proteins. Peritubular dentin delimits the dentinal tubule. This dentin is poor in collagen and more mineralized than the rest of the dentin.[30] The arrangement of collagen fibrils in dentin, specifically in the intertubular dentin, can be described as radial fibril arrays. With the collagen fibrils in the plane parallel to the surface at which dentin formation takes place in the pulp cavity, the dentin structure is highly anisotropic (i.e., its physical properties vary depending on directionality). However, within the collagen fiber, the fibril bundles are randomly and poorly oriented. Furthermore, the crystal layers within the fibril bundles also are randomly placed. This random orientation of crystals within dentin collagen fibers provides isotropic elastic and hardness properties. Despite the isotropic elasticity of dentin structures, the fracture properties of dentin are anisotropic, in which the crack follows the plane of mineralized dentin collagen fibrils.[21]

2. Repair and regeneration process

The major clinical consequence of the difference between bone and dentin is how they heal in response to injury. While the bone healing process is regenerative, the dentin’s healing process is an imperfect repair mechanism that results in a structure that differs significantly from the original tissue.[70]

Tertiary dentin—formed in response to irritating stimuli—can be classified into reactionary and reparative dentin (Fig. 2). Reactionary dentin is formed after a milder stimulus in which primary odontoblasts survive the injury. In such cases, growth factors from the matrix reach the existing odontoblasts at the injury site to increase the secretion rate of the matrix. Down-regulation of odontoblast secretion by autophagy during secondary dentinogenesis is up-regulated again during reactionary dentinogenesis via the p38-MAPK pathway. This happens probably through a combination of bacterial stimulants and the release of fossilized growth factors and bioactive molecules derived from demineralized primary and secondary dentin matrix. Upon histological observations, it was found that reactionary variants—classified by the continuity of the tertiary dentin with the secondary dentine—had sparsely distributed tubules that ran irregularly.[70]

Fig. 2

Schematic illustration of tertiary dentinogenesis, reactionary and reparative dentin formation.

In contrast, reparative dentin is formed in response to a stronger stimulus that kills the primary odontoblasts. This type of dentin requires molecular signals from dentin matrix-derived growth factors to induce migration, proliferation, and differentiation of the progenitor cells to odontoblast-like cells, which then replace the dead odontoblasts and secrete a new dentin matrix. Three possible theories explain the origin of these odontoblast-like cells. First, it has been suggested that one of the daughter cells is positioned at the dental basal membrane during the pre-odontoblasts’ last cell division, right before the terminal differentiation. When the inductive signals are given (e.g., bacterial stimulants or fossilized growth factors released from the demineralized matrix diffuse into the area where these daughter cells are located), these cells differentiate into the odontoblasts. In order to become odontoblast-like cells during the tertiary dentinogenesis, the daughter cells migrate into the Höhl layer of the dental pulp. Second, it has been suggested that the cells in the pulp tissue (pericytes, fibroblasts, and endothelial cells, which can be found in the pulp’s bipolar zone), may convert into undifferentiated mesenchymal stem cells. These cells then re-differentiate into odontoblast-like cells. A definitive mechanism explaining these steps has not been found. Third, the existence of multipotent adult stem cells has been suggested. While these cells may play a key role in tertiary dentinogenesis, it is not certain whether they migrate to the injury site via the pulp tissue vasculature or have a developmental derivation from dental papilla.[71]

Reparative dentin can be classified into either osteodentin or orthodentin. The orthodentin type has tubules but no cell inclusions.[4] Poorer repairs lead to the osteodentin type, which—unlike a typical odontoblast cell—resembles bone osteocytes that are entrapped in the reparative dentin with a strong expression of BSP.[72] It was found that when there is a cavity large enough to result in the absence of odontoblasts near the injury site, an amorphous, atubular calcified tissue (not continuous with the primary or secondary dentin structure) was laid down. It is hypothesized that this calcified tissue, uncharacteristic of dentin, may result from the proliferation of fibroblasts, the predominant cell type in the ECM of the dental pulp, may outcompete that of the progenitor cells following the death of primary odontoblasts.[70] Generally, when human dentin pulp stem cells are induced to differentiate into odontoblast-like cells, they are involved in reparative dentin formation. When carious insults demineralize the dentin, growth factors embedded in the dentin matrix diffuse into the pulp stem cell layers. One of the biomolecules involved in signaling the pulp stem cells is TGF-β. TGF-β is known to be heavily involved in the wound-healing process, where it contributes to fibrosis formation. We posit that TGF-β is the key molecule signaling the pulp stem cells to differentiate into the fibroblasts that creates reparative dentin. Interestingly, it has been suggested that CPNE7 molecules induce differentiation of odontoblast-like cells from mesenchymal cells of dental or non-dental origin.[73] Current research on CPNE7 molecules has shown that when pulp stem cells are induced by CPNE7, they not only have the ability to differentiate into the odontoblast-like cells, but they also form the dentin structure that is similar to reactionary dentin.[74] From this result, we can infer that the CPNE7 molecule is essential in making the physiologic reactionary dentin with dentinal tubular structures during the process of tertiary dentinogenesis. However, the exact biological mechanism of this process is unknown.


In this article, we described similarities and differences in bone and dentin, emphasizing the healing process of each. Bone and dentin share similar characteristics in their composition, biomarkers, and clinical manifestations in the case of mineralization defects. There has been a shift in thought that some of the matrix-derived proteins traditionally described as either dentin- or bone-specific should not be described as such since it was recently determined that such proteins are expressed in both tissues, albeit at a lower level. Some of the key differences are the presence of dentinal tubules, vascularity, and the ability to remodel throughout the lifespan. Due to these morphological differences, we determined that bone has a more effective regenerative process than dentin.



This work was supported by Basic Science Research Program through the Ministry of Education of the Republic of Korea and National Research Foundation (Grant Nos. NRF 2019R1A2C2003346 and NRF-2018R1A5A2024418).

Ethics approval and consent to participate

Not applicable.

Conflict of interest

No potential conflict of interest relevant to this article was reported.


1. Qin C, Baba O, Butler WT. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med 2004;15:126–36. .
2. Lin X, Patil S, Gao YG, et al. The bone extracellular matrix in bone formation and regeneration. Front Pharmacol 2020;11:757. .
3. Marinovich R, Soenjaya Y, Wallace GQ, et al. The role of bone sialoprotein in the tendon-bone insertion. Matrix Biol 2016;52–54:325–38. .
4. Goldberg M, Six N, Decup F, et al. Bioactive molecules and the future of pulp therapy. Am J Dent 2003;16:66–76.
5. Wan C, Yuan G, Luo D, et al. The dentin sialoprotein (DSP) domain regulates dental mesenchymal cell differentiation through a novel surface receptor. Sci Rep 2016;6:29666. .
6. Jani PH, Gibson MP, Liu C, et al. Transgenic expression of Dspp partially rescued the long bone defects of Dmp1-null mice. Matrix Biol 2016;52–54:95–112. .
7. Maciejewska I, Cowan C, Svoboda K, et al. The NH2-terminal and COOH-terminal fragments of dentin matrix protein 1 (DMP1) localize differently in the compartments of dentin and growth plate of bone. J Histochem Cytochem 2009;57:155–66. .
8. Singh A, Gill G, Kaur H, et al. Role of osteopontin in bone remodeling and orthodontic tooth movement: a review. Prog Orthod 2018;19:18. .
9. Reinholt FP, Hultenby K, Oldberg A, et al. Osteopontin--a possible anchor of osteoclasts to bone. Proc Natl Acad Sci U S A 1990;87:4473–5. .
10. Zelenchuk LV, Hedge AM, Rowe PS. Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motif. Bone 2015;79:131–42. .
11. Goldberg M, Kulkarni AB, Young M, et al. Dentin: structure, composition and mineralization. Front Biosci (Elite Ed) 2011;3:711–35. .
12. Addison WN, Nakano Y, Loisel T, et al. MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite: an inhibition regulated by PHEX cleavage of ASARM. J Bone Miner Res 2008;23:1638–49. .
13. Rowe PS, Kumagai Y, Gutierrez G, et al. MEPE has the properties of an osteoblastic phosphatonin and minhibin. Bone 2004;34:303–19. .
14. Opsahl Vital S, Gaucher C, Bardet C, et al. Tooth dentin defects reflect genetic disorders affecting bone mineralization. Bone 2012;50:989–97. .
15. Millington-Ward S, McMahon HP, Farrar GJ. Emerging therapeutic approaches for osteogenesis imperfecta. Trends Mol Med 2005;11:299–305. .
16. Ibrahim S, Strange AP, Aguayo S, et al. Phenotypic properties of collagen in dentinogenesis imperfecta associated with osteogenesis imperfecta. Int J Nanomedicine 2019;14:9423–35. .
17. Rutkovskiy A, Stensløkken KO, Vaage IJ. Osteoblast differentiation at a glance. Med Sci Monit Basic Res 2016;22:95–106. .
18. Dallas SL, Prideaux M, Bonewald LF. The osteocyte: an endocrine cell ... and more. Endocr Rev 2013;34:658–90. .
19. Kim JH, Kim N. Signaling pathways in osteoclast differentiation. Chonnam Med J 2016;52:12–7. .
20. Burr DB, Allen MR, eds. Basic and applied bone biology 2nd edth ed. London, UK: Elsevier; 2019.
21. Weiner S, Wagner HD. The material bone: Structure-mechanical function relations. Annu Rev Mater Sci 1998;28:271–98.
22. Lowenstam HA, Weiner S. On biomineralization New York, NY: Oxford University Press; 1989.
23. Siperko LM, Landis WJ. Atomic force microscopy imaging of hydroxyapatite. J Mater Sci Lett 1993;12:1068–9.
24. Hay ED, ed. Cell biology of extracellular matrix 2nd edth ed. New York, NY: Plenum; 1991.
25. Delmas PD, Tracy RP, Riggs BL, et al. Identification of the noncollagenous proteins of bovine bone by two-dimensional gel electrophoresis. Calcif Tissue Int 1984;36:308–16. .
26. Katz EP, Li ST. Structure and function of bone collagen fibrils. J Mol Biol 1973;80:1–15. .
27. McCutchen CW. Do mineral crystals stiffen bone by straitjacketing its collagen? J Theor Biol 1975;51:51–8. .
28. Reid SA. Micromorphological characterisation of normal human bone surfaces as a function of age. Scanning Microsc 1987;1:579–97.
29. Bourne GH. The biochemistry and physiology of bone 2nd edth ed. New York, NY: Academic Press; 1971.
30. Nanci A, ed. Ten Cate’s oral histology 9th edth ed. St. Louis, MO: Elsevier; 2017.
31. Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol 2012;8:133–43. .
32. Marsell R, Einhorn TA. The biology of fracture healing. Injury 2011;42:551–5. .
33. Ghiasi MS, Chen J, Vaziri A, et al. Bone fracture healing in mechanobiological modeling: A review of principles and methods. Bone Rep 2017;6:87–100. .
34. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998;:S7–21. .
35. Mandracchia VJ, Nelson SC, Barp EA. Current concepts of bone healing. Clin Podiatr Med Surg 2001;18:55–77.
36. Gerstenfeld LC, Cullinane DM, Barnes GL, et al. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 2003;88:873–84. .
37. Saran U, Gemini Piperni S, Chatterjee S. Role of angiogenesis in bone repair. Arch Biochem Biophys 2014;561:109–17. .
38. Barnes GL, Kostenuik PJ, Gerstenfeld LC, et al. Growth factor regulation of fracture repair. J Bone Miner Res 1999;14:1805–15. .
39. Hauser CJ, Zhou X, Joshi P, et al. The immune microenvironment of human fracture/soft-tissue hematomas and its relationship to systemic immunity. J Trauma 1997;42:895–903. discussion -4. .
40. Carano RA, Filvaroff EH. Angiogenesis and bone repair. Drug Discov Today 2003;8:980–9. .
41. Glowacki J. Angiogenesis in fracture repair. Clin Orthop Relat Res 1998;:S82–9. .
42. Brandi ML, Collin-Osdoby P. Vascular biology and the skeleton. J Bone Miner Res 2006;21:183–92. .
43. Chim SM, Tickner J, Chow ST, et al. Angiogenic factors in bone local environment. Cytokine Growth Factor Rev 2013;24:297–310. .
44. Malda J, Klein TJ, Upton Z. The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng 2007;13:2153–62. .
45. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 1999;26:74–84. .
46. Lu C, Marcucio R, Miclau T. Assessing angiogenesis during fracture healing. Iowa Orthop J 2006;26:17–26.
47. Street J, Bao M, deGuzman L, et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A 2002;99:9656–61. .
48. Eckardt H, Ding M, Lind M, et al. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br 2005;87:1434–8. .
49. Mayr-Wohlfart U, Waltenberger J, Hausser H, et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002;30:472–7. .
50. Street J, Winter D, Wang JH, et al. Is human fracture hematoma inherently angiogenic? Clin Orthop Relat Res 2000;:224–37. .
51. Street JT, Wang JH, Wu QD, et al. The angiogenic response to skeletal injury is preserved in the elderly. J Orthop Res 2001;19:1057–66. .
52. Rhinelander FW. Tibial blood supply in relation to fracture healing. Clin Orthop Relat Res 1974;:34–81.
53. Peng H, Usas A, Olshanski A, et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 2005;20:2017–27. .
54. Beamer B, Hettrich C, Lane J. Vascular endothelial growth factor: an essential component of angiogenesis and fracture healing. HSS J 2010;6:85–94. .
55. Zelzer E, McLean W, Ng YS, et al. Skeletal defects in VEGF (120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 2002;129:1893–904.
56. Deckers MM, Karperien M, van der Bent C, et al. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 2000;141:1667–74. .
57. Deckers MM, van Bezooijen RL, van der Horst G, et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002;143:1545–53. .
58. Ferguson C, Alpern E, Miclau T, et al. Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 1999;87:57–66. .
59. Tatsuyama K, Maezawa Y, Baba H, et al. Expression of various growth factors for cell proliferation and cytodifferentiation during fracture repair of bone. Eur J Histochem 2000;44:269–78.
60. Rosier RN, O’Keefe RJ, Hicks DG. The potential role of transforming growth factor beta in fracture healing. Clin Orthop Relat Res 1998;:S294–300. .
61. Bostrom MP, Asnis P. Transforming growth factor beta in fracture repair. Clin Orthop Relat Res 1998;:S124–31. .
62. Hing KA. Bone repair in the twenty-first century: biology, chemistry or engineering? Philos Trans A Math Phys Eng Sci 2004;362:2821–50. .
63. Montesano R, Vassalli JD, Baird A, et al. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A 1986;83:7297–301. .
64. Collin-Osdoby P, Rothe L, Bekker S, et al. Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J Bone Miner Res 2002;17:1859–71. .
65. Globus RK, Patterson-Buckendahl P, Gospodarowicz D. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. Endocrinology 1988;123:98–105. .
66. Smith AJ, Murray PE, Sloan AJ, et al. Trans-dentinal stimulation of tertiary dentinogenesis. Adv Dent Res 2001;15:51–4. .
67. Unda FJ, Martín A, Hilario E, et al. Dissection of the odontoblast differentiation process in vitro by a combination of FGF1, FGF2, and TGFbeta1. Dev Dyn 2000;218:480–9.<480::Aid-dvdy1011>3.0.Co;2-o .
68. Oka S, Oka K, Xu X, et al. Cell autonomous requirement for TGF-beta signaling during odontoblast differentiation and dentin matrix formation. Mech Dev 2007;124:409–15. .
69. He WX, Niu ZY, Zhao SL, et al. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line. Arch Oral Biol 2004;49:911–8. .
70. Ricucci D, Loghin S, Lin LM, et al. Is hard tissue formation in the dental pulp after the death of the primary odontoblasts a regenerative or a reparative process? J Dent 2014;42:1156–70. .
71. Dammaschke T. The formation of reparative dentine and Höhl cells in the dental pulp. ENDO (Lond Engl) 2010;4:255–61.
72. Hwang YC, Hwang IN, Oh WM, et al. Influence of TGF-beta1 on the expression of BSP, DSP, TGF-beta1 receptor I and Smad proteins during reparative dentinogenesis. J Mol Histol 2008;39:153–60. .
73. Oh HJ, Choung HW, Lee HK, et al. CPNE7, a preameloblast-derived factor, regulates odontoblastic differentiation of mesenchymal stem cells. Biomaterials 2015;37:208–17. .
74. Choung HW, Lee DS, Lee JH, et al. Tertiary dentin formation after indirect pulp capping using protein CPNE7. J Dent Res 2016;95:906–12. .

Article information Continued

Fig. 1

Schematic representation of secondary bone healing process in 4 overlapping stages.

Fig. 2

Schematic illustration of tertiary dentinogenesis, reactionary and reparative dentin formation.